Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1990 Mar 15;142(6):543–544.

Mupirocin in the treatment of impetigo. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

PMCID: PMC1451875  PMID: 2107019

Full text

PDF
543

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURNETT J. W. The route of antibiotic administration in superficial impetigo. N Engl J Med. 1963 Jan 10;268:72–75. doi: 10.1056/NEJM196301102680203. [DOI] [PubMed] [Google Scholar]
  2. Baltimore R. S. Treatment of impetigo: a review. Pediatr Infect Dis. 1985 Sep-Oct;4(5):597–601. doi: 10.1097/00006454-198509000-00061. [DOI] [PubMed] [Google Scholar]
  3. Blumer J. L., Lemon E., O'Horo J., Snodgrass D. J. Changing therapy for skin and soft tissue infections in children: have we come full circle? Pediatr Infect Dis J. 1987 Jan;6(1):117–122. doi: 10.1097/00006454-198701000-00052. [DOI] [PubMed] [Google Scholar]
  4. Casewell M. W., Hill R. L. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')--a controlled trial. J Antimicrob Chemother. 1986 Mar;17(3):365–372. doi: 10.1093/jac/17.3.365. [DOI] [PubMed] [Google Scholar]
  5. Casewell M. W., Hill R. L. Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent. J Antimicrob Chemother. 1987 Jan;19(1):1–5. doi: 10.1093/jac/19.1.1. [DOI] [PubMed] [Google Scholar]
  6. Dajani A. S., Ferrieri P., Wannamaker L. W. Natural history of impetigo. II. Etiologic agents and bacterial interactions. J Clin Invest. 1972 Nov;51(11):2863–2871. doi: 10.1172/JCI107109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Derrick C. W., Dillon H. C., Jr Further studies on the treatment of streptococcal skin infection. J Pediatr. 1970 Oct;77(4):696–700. doi: 10.1016/s0022-3476(70)80218-9. [DOI] [PubMed] [Google Scholar]
  8. Dillon H. C., Derrick C. W. Clinical experience with clindamycin hydrochloride: I. Treatment of streptococcal and mixed streptococcal-staphylococcal skin infections. Pediatrics. 1975 Feb;55(2):205–212. [PubMed] [Google Scholar]
  9. Dillon H. C., Jr The treatment of streptococcal skin infections. J Pediatr. 1970 May;76(5):676–684. doi: 10.1016/s0022-3476(70)80284-0. [DOI] [PubMed] [Google Scholar]
  10. Eells L. D., Mertz P. M., Piovanetti Y., Pekoe G. M., Eaglstein W. H. Topical antibiotic treatment of impetigo with mupirocin. Arch Dermatol. 1986 Nov;122(11):1273–1276. [PubMed] [Google Scholar]
  11. Ferrieri P., Dajani A. S., Wannamaker L. W. A controlled study of penicillin prophylaxis against streptococcal impetigo. J Infect Dis. 1974 Apr;129(4):429–438. doi: 10.1093/infdis/129.4.429. [DOI] [PubMed] [Google Scholar]
  12. Fuller A. T., Mellows G., Woolford M., Banks G. T., Barrow K. D., Chain E. B. Pseudomonic acid: an antibiotic produced by Pseudomonas fluorescens. Nature. 1971 Dec 17;234(5329):416–417. doi: 10.1038/234416a0. [DOI] [PubMed] [Google Scholar]
  13. Goldfarb J., Crenshaw D., O'Horo J., Lemon E., Blumer J. L. Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo. Antimicrob Agents Chemother. 1988 Dec;32(12):1780–1783. doi: 10.1128/aac.32.12.1780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gratton D. Topical mupirocin versus oral erythromycin in the treatment of primary and secondary skin infections. Int J Dermatol. 1987 Sep;26(7):472–473. doi: 10.1111/j.1365-4362.1987.tb00600.x. [DOI] [PubMed] [Google Scholar]
  15. Hill R. L., Duckworth G. J., Casewell M. W. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother. 1988 Sep;22(3):377–384. doi: 10.1093/jac/22.3.377. [DOI] [PubMed] [Google Scholar]
  16. Hirschmann J. V. Topical antibiotics in dermatology. Arch Dermatol. 1988 Nov;124(11):1691–1700. [PubMed] [Google Scholar]
  17. Hughes J., Mellows G. On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo) 1978 Apr;31(4):330–335. doi: 10.7164/antibiotics.31.330. [DOI] [PubMed] [Google Scholar]
  18. Hughes W. T., Wan R. T. Impetigo contagiosa: etiology, complications, and comparison of therapeutic effectiveness of erythromycin and antibiotic ointment. Am J Dis Child. 1967 Apr;113(4):449–453. doi: 10.1001/archpedi.1967.02090190095008. [DOI] [PubMed] [Google Scholar]
  19. Reilly G. D., Spencer R. C. Pseudomonic acid--a new antibiotic for skin infections. J Antimicrob Chemother. 1984 Mar;13(3):295–298. doi: 10.1093/jac/13.3.295. [DOI] [PubMed] [Google Scholar]
  20. Ruby R. J., Nelson J. D. The influence of hexachlorophene scrubs on the response to placebo or penicillin therapy in impetigo. Pediatrics. 1973 Dec;52(6):854–859. [PubMed] [Google Scholar]
  21. Rumsfield J., West D. P., Aronson I. K. Topical mupirocin in the treatment of bacterial skin infections. Drug Intell Clin Pharm. 1986 Dec;20(12):943–948. doi: 10.1177/106002808602001204. [DOI] [PubMed] [Google Scholar]
  22. Sutherland R., Boon R. J., Griffin K. E., Masters P. J., Slocombe B., White A. R. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother. 1985 Apr;27(4):495–498. doi: 10.1128/aac.27.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ward A., Campoli-Richards D. M. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1986 Nov;32(5):425–444. doi: 10.2165/00003495-198632050-00002. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES